Hypermobility​

Dr. Najla Alsiri stands at the forefront of medical innovation, boasting a rare subspecialty in Hypermobility and connective tissue disorders. Her impressive qualifications in orthopedic pathokinesiology, rehabilitation, and clinical research paved the way for her to establish the first Hypermobility clinic in the Middle East.

In a short span, this clinic earned accolades from the top hypermobility society worldwide, specifically recognized by the Ehlers-Danlos Syndrome as an excellence clinic. Dr. Alsiri’s dedication pushed the boundaries of conventional care, establishing a multidisciplinary team comprising rheumatology, physiotherapy, occupational therapy, and nutritionists. This collaborative approach is rooted in her vision that Hypermobility should be acknowledged as a potential cause for various epidemic conditions and injuries, ranging from osteoarthritis to scoliosis, impacting the entire body’s joints and systems.

Dr. Alsiri’s commitment extends beyond clinical practice. She has amassed a wealth of publications and undertaken projects on a national and international scale. Leveraging her biomechanical background, she enriches patient analysis and management through an advanced telehealth system.
This innovative approach, coupled with culturally adapted outcome measures, showcases her holistic and patient-centric approach to healthcare, promising to change the landscape of diagnosis and management for those with hypermobility and connective tissue disorders.